aid: 3dcellbioprintingconsortium
name: 3D Cell Bioprinting Consortium
description: >-
  The 3D Cell Bioprinting Consortium (traded on the EquityZen secondary marketplace under the
  symbol TDCC) is an alliance of laboratory-instrument and biomaterials companies formed in
  2016 and publicly launched in February 2017, headquartered in Marlborough, Massachusetts.
  It describes itself as "a group of companies focused on offering the complete solution for
  tissue engineering" — coordinating bioprinter hardware, bioinks and hydrogels, cell lines
  and culture reagents into a single workflow for pre-clinical drug discovery, regenerative
  medicine and diagnostics. It was founded by Sid Braginsky, CEO and Chairman of Digilab
  Corp., and its named members include Digilab, Inc. (maker of the CellJet cell printer,
  represented by President and COO John Moore) and 3-D Matrix, Inc. (self-assembling peptide
  hydrogels, represented by Managing Director Marc Rioult). The consortium is a coordinating
  body for physical laboratory products, not a software vendor: it publishes no first-party
  website, developer portal, documentation, SDK, or machine-readable API specification, and
  no domain matching its name resolves in DNS. This profile is an independent third-party
  record; there is no API surface to enrich.
url: https://raw.githubusercontent.com/api-evangelist/3dcellbioprintingconsortium/refs/heads/main/apis.yml
x-harvest-source-url: https://equityzen.com/company/3dcellbioprintingconsortium/
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-api-surface
x-founded: '2016'
x-headquarters: Marlborough, Massachusetts, United States
x-domain-status: none
x-domain-note: >-
  No first-party domain was found. Six name-derived candidates were probed and every one is
  NXDOMAIN (3dcellbioprintingconsortium.com/.org, 3dcellbioprinting.com/.org,
  bioprintingconsortium.org, cellbioprintingconsortium.com). The only reachable record of the
  company is the EquityZen secondary-market listing, which is a trading venue and NOT the
  company's web presence, so it is recorded as x-harvest-source-url and is deliberately not
  wired as a Website pointer (roadmap#56). Note also that digilabglobal.com — the former host
  of founding member Digilab, Inc. — has been re-registered and now serves an unrelated
  online-gambling site, so it is not usable as a consortium surface either.
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Consortium
- Bioprinting
- Tissue Engineering
- Life Sciences
- Biotechnology
- Regenerative Medicine
- Laboratory Instruments
- Biomaterials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    The consortium is a marketing and coordination alliance for bioprinter hardware, bioinks
    and cell-culture reagents — physical laboratory products — and it publishes no web
    presence of its own at all: every name-derived domain is NXDOMAIN and the only reachable
    record is its EquityZen secondary-market listing, so there is no host on which a
    developer program, spec or /.well-known surface could exist.
  evidence:
  - url: https://equityzen.com/company/3dcellbioprintingconsortium/
    status: 200
  - url: https://3dcellbioprintingconsortium.com/
    status: 0
  - url: https://3dcellbioprinting.com/
    status: 0
  - url: https://bioprintingconsortium.org/
    status: 0
  - url: https://www.crunchbase.com/organization/3d-cell-bioprinting-consortium
    status: 403
  - url: https://api.github.com/orgs/3dcellbioprintingconsortium
    status: 404
  checked: '2026-09-05'
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 0
  pass: local-v3